24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

EMPAG Posters 0<br />

EP13.2<br />

Decision making dilemmas for E-cadherin mutation carriers: A<br />

family case study<br />

S. C. Downing;<br />

Department <strong>of</strong> Medical <strong>Genetics</strong>, Addenbrookes Hospital, Cambridge, United<br />

Kingdom.<br />

This case study presents two siblings, whose health beliefs, career and<br />

family responsibility had a strong influence on how they perceived their<br />

risk, management choices and decisions . Both were carriers <strong>of</strong> an Ecadherin<br />

(CDH1) mutation and chose to manage their risks differently .<br />

Gastric cancer affects 15 per 100,000 people in the UK and around 3%<br />

arise from a clearly identified inherited gastric cancer predisposition.<br />

One third <strong>of</strong> families with a strong history <strong>of</strong> diffuse gastric cancer have<br />

germ line mutations in the E-cadherin gene . Mutation carriers have a<br />

70-80% life time risk <strong>of</strong> developing gastric cancer with associated poor<br />

outcome, they also have an increased risk <strong>of</strong> lobular breast cancer<br />

and colon cancer . Predictive testing is available for individuals where<br />

a familial mutation has been identified. A positive result provides challenging<br />

decisions regarding personal risk management with the option<br />

<strong>of</strong> endoscopic screening or prophylactic gastrectomy . Screening is unproven<br />

and there is concern that early cancer may be missed since it<br />

is submucosal . The alternative option <strong>of</strong> surgery carries a high morbidity<br />

with life long adaptations required; limited data exists on the outcome<br />

for prophylactic gastrectomy . One sibling opted for preventative<br />

surgery, the other endoscopy screening . Counselling issues included:<br />

career changes, family dynamics, psychosocial aspects, coping with<br />

major surgery, and quality <strong>of</strong> life . Management <strong>of</strong> cancer risk is a personal<br />

issue, risk management options should be explored in depth to<br />

enable the individual to make fully informed decisions .<br />

EP13.3<br />

Quality <strong>of</strong> life in adults with familial adenomatous polyposis<br />

(FAP)<br />

K. Fritzell 1 , J. Björk 1 , M. Arman 2 , R. Hultcrantz 1 , L. Wettergren 2 ;<br />

1 The Swedish Polyposis Registry, Stockholm, Sweden, 2 Department <strong>of</strong> Neurobiology,<br />

Care Sciences and <strong>Society</strong>, Karolinska Institutet, Stockholm, Sweden.<br />

Background: FAP is a disease which among other symptoms is manifested<br />

as multiple polyposis with adenomas in the large intestine, rectum<br />

and duodenum . These adenomas are very likely to turn cancerous<br />

over time . The disease is inherited autosomal dominant . Surgery is<br />

the only treatment that can prevent colorectal cancer and prophylactic<br />

surgery is performed on all patients . Preoperative symptoms are rare,<br />

but a large number <strong>of</strong> patients report functional impairments after surgery<br />

.<br />

Aim: The aim <strong>of</strong> the study was to describe how adult patients with FAP<br />

perceive that the disease has affected their life .<br />

Method: Adult patients (≥20 years) attending the outpatient clinic at<br />

The Swedish Polyposis Registry were invited to participate in focus<br />

group interviews (n=43) . Three focus group interviews were conducted<br />

. Data was analysed by means <strong>of</strong> content analysis .<br />

Results: The content analysis revealed nine themes: Worries and concerns,<br />

Social life, Choice <strong>of</strong> career and education, Risk <strong>of</strong> giving the<br />

disease to the children, Changed food and toilet habits, Experiences<br />

<strong>of</strong> endoscopic examinations, Relationships to health care providers,<br />

Stories about hospital stay at their first surgery, Knowledge <strong>of</strong> FAP.<br />

Conclusion: The study has highlighted several issues <strong>of</strong> concerns related<br />

to FAP . Worries about getting worse due to the disease were expressed<br />

by many <strong>of</strong> the participants but not anyone mentioned cancer<br />

as a threat for future health . Due to the heredity <strong>of</strong> the disease, having<br />

own children or not was a deep and complex question and the discussion<br />

gave an impression <strong>of</strong> a need to defend one’s standpoint .<br />

EP13.4<br />

Participation in Huntington‘s disease research:hoping, coping<br />

and a nice day out<br />

J. Needs;<br />

Cardiff University, Cardiff, United Kingdom.<br />

This poster is based on an ongoing PhD examining Huntington’s disease<br />

(HD) as a case study <strong>of</strong> how the development <strong>of</strong> genetic technologies<br />

and identification <strong>of</strong> human genetic mutations, affect the work <strong>of</strong><br />

the clinic and the lives <strong>of</strong> patients . Ethnographic data from neurological<br />

research clinics (n=11) will be used to explore the current nature and<br />

structure <strong>of</strong> clinical work itself, and will illustrate how different mean-<br />

ings <strong>of</strong> the clinic are enacted by the participants, including patients,<br />

family members, carers, and researchers . This work will be used to inform<br />

later stages <strong>of</strong> the PhD, which will include interviews with patients<br />

and clinical teams and the examination <strong>of</strong> an archive <strong>of</strong> HD patient<br />

records from the 1970’sto the present day .<br />

Current clinical practice emphasises genetic, biological, cognitive and<br />

physical measurement . These are areas associated with neuroscientific<br />

research programmes, and patient recruitment is crucial in order<br />

to provide large data sets for possible future clinical trials . These data<br />

sets will be kept indefinitely and provide material for international collaborative<br />

research . However, for patients and families, research involvement<br />

is not always the focus . Rather, they view participation as a<br />

privileged medical appointment and a way <strong>of</strong> getting answers to their<br />

own situations . They hope for effective treatment via research (stem<br />

cells) and participation may provide one strategy for coping with the<br />

effects <strong>of</strong> the disease . The research environment and relationships<br />

with researchers at repeated clinic visits also provides familiarity and a<br />

social aspect to the whole process, in effect, a nice day out .<br />

EP13.5<br />

Consensus document on best care in HD: a training/educational<br />

program for italian neurologists<br />

G. Jacopini 1 , P. Zinzi 1 , A. R. Bentivoglio 2 , M. Frontali 3 ;<br />

1 ISTC/National Research Council, Rome, Italy, 2 Istituto di Neurologia Università<br />

Cattolica del Sacro Cuore, Policlinico “A.Gemelli”, Rome, Italy, 3 INMM/National<br />

Research Council, Rome, Italy.<br />

Huntington’s disease is a rare, complex, hereditary disorder, characterized<br />

by motor as well as psychiatric symptoms; very <strong>of</strong>ten, neurologists<br />

are unable to handle these patients, lacking guidelines about the<br />

most appropriate way <strong>of</strong> care for them . In July 2007, upon request<br />

<strong>of</strong> the Italian Association for Huntington’s Chorea (A .I .C .H-Rome and<br />

A .I .C .H-Milan), our research group organized a multidisciplinary panel<br />

<strong>of</strong> experts with the main task <strong>of</strong> providing recommendations for the<br />

best care in HD . The panel produced a “consensus document” with recommendations<br />

which address HD patients and families’ main needs,<br />

combining together scientific information and long lasting clinical experience<br />

. The document covers multiple aspects: making the diagnosis<br />

and communicating it, therapeutic management and paramedical<br />

treatments, nutrition and dietary supplements, genetic risk and genetic<br />

testing protocol, co-morbidity, palliative and end-<strong>of</strong>-life care, non medical<br />

support, indications for referral .<br />

The document, written in a synthetic style, contains practical recommendations<br />

aimed at minimize inappropriate care and introducing research<br />

findings into clinical practice <strong>of</strong> neurologists not familiar with<br />

HD issues . The document will be printed (10 .000 copies) and, starting<br />

May <strong>2008</strong>, first introduced in the course <strong>of</strong> three main educational<br />

events (in Northern, Central and Southern Italy) for neurologists . Then<br />

the document will be delivered to 3,500 neurologists working both in<br />

public health care settings and in the private field. In the future we plan<br />

to assess the impact <strong>of</strong> the document through meaningful and measurable<br />

outcomes .<br />

EP13.6<br />

Living with a person with Huntington‘s disease<br />

A. J. A. G. Van Tongerloo, A. M. J. J. De Paepe;<br />

University Hospital Gent, Gent, Belgium.<br />

Introduction: Huntington’s disease, an autosomal dominant neurodegenerative<br />

disorder, is characterized by a triad <strong>of</strong> progressive motor,<br />

cognitive and emotional symptoms . In 1994, predictive testing through<br />

the direct DNA test became available . The psychological impact <strong>of</strong> carriership<br />

on the testee and his/her partner has been extensively evaluated<br />

and reviewed . Few studies however, have been conducted to<br />

explore how living with a person with the disease affects the healthy<br />

partner’s daily life .<br />

Materials and Methods: In January <strong>2008</strong>, a qualitative study was set<br />

up, in which partners <strong>of</strong> persons with HD are questioned through a<br />

semi-structured interview . Topics that are questioned are: coping with<br />

the partner’s symptoms, the symptoms that are the most difficult to<br />

deal with, the changes in personal life <strong>of</strong> the healthy partner, and the<br />

future perspectives for the healthy partners . Furthermore, participants<br />

are asked about their feelings towards their partner, and about communication<br />

on the disease with the affected partner, with their children<br />

and with significant others.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!